RxDoctor Payments DataLook up a doctor →

NovoSeven RT: payments to doctors

Payments that named NovoSeven RT as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$385K
Providers
280
Transactions
523
Average per transaction
$736

The per-transaction average — $736 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 280 providers the average total is $1,375, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novo Nordisk$323,37084.0%
Novo Nordisk AS$34,3438.9%
Novo Nordisk Health Care AG$27,2847.1%
← All drugs & devices